证券代码：300797 证券简称：钢研纳克 公告编号：2023-034 钢研纳克检测技术股份有限公司 关于更换证券事务代表的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 钢研纳克检测技术股份有限公司（以下简称"钢研纳克"或"公司"）董事会近日收到蔡翔 先生的书面辞职报告，蔡翔先生因个人原因申请辞去公司证券事务代表职务，辞职报告自送 达董事会之日起生效。辞职后，蔡翔先生将不在公司担任任何职务。 蔡翔先生在担任公司证券事务代表期间恪尽职守、勤勉尽责，公司及董事会对蔡翔先生 在任职期间的辛勤工作和为公司发展做出的突出贡献表示衷心感谢。 公司于 2023 年 8 月 23 日召开第二届董事会第十八次会议，审议通过了《关于钢研纳克 检测技术股份有限公司更换证券事务代表的议案》，聘任陈俊宇先生为公司证券事务代表， 协助董事会秘书履行职责，任期自本次董事会审议通过之日起至本届董事会任期届满日止。 陈俊宇先生已取得上海证券交易所主板董事会秘书资格与上海证券交易所科创板董事 会秘书资格。具备担任公司证券事务代表所必需的专业知识和相关工作经验，其任职资格符 合《深圳证券交 ...

证券代码：300797 证券简称：钢研纳克 公告编号：2023-036 钢研纳克检测技术股份有限公司 关于第二届监事会第十七次会议决议的公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、监事会召开情况 钢研纳克检测技术股份有限公司（以下简称"公司"）第二届监事会第十七次会议于 2023 年 8 月 23 日在北京市海淀区高梁桥斜街 13 号新材料大楼十层第一会议室召开，会议通知于 2023 年 8 月 11 日以专人送出、电子邮件等方式送达全体监事。 会议由公司监事会主席金戈女士主持。本次会议应出席监事人数 3 人，实际出席监事人 数 3 人。出席监事资格、人数以及召集、召开程序等均符合《中华人民共和国公司法》等法 律法规和《钢研纳克检测技术股份有限公司章程》的规定，本次会议合法有效。 二、监事会会议审议情况 经与会监事充分讨论，本次会议审议并通过了如下议案： 1、审议通过《关于<钢研纳克检测技术股份有限公司 2023 年半年度报告>及其摘要的 议案》 经审议，监事会一致同意《钢研纳克检测技术股份有限公司 2023 年半年度报告》及其 摘要。 表决结果 ...

证券代码：300797 证券简称：钢研纳克 公告编号：2023-035 钢研纳克检测技术股份有限公司 关于第二届董事会第十九次会议决议的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会召开情况 钢研纳克检测技术股份有限公司（以下简称"公司"）第二届董事会第十七次会议于 2023 年 8 月 23 日在北京市海淀区高梁桥斜街 13 号新材料大楼十层第一会议室召开，会议通知于 2023 年 8 月 11 日以专人送出、电子邮件等方式送达全体董事。 会议由公司董事长杨植岗先生主持，公司监事与高级管理人员列席了本次会议。本次会 议应出席董事人数 7 人，实际出席董事人数 7 人。出席董事资格、人数以及召集、召开程序 等均符合《中华人民共和国公司法》等法律法规和《钢研纳克检测技术股份有限公司章程》 的规定，本次会议合法有效。 二、董事会会议审议情况 经与会董事充分讨论，本次会议审议并通过了如下议案： 1、审议通过《关于<钢研纳克检测技术股份有限公司 2023 年半年度报告>及其摘要的 议案》 经审议，董事会一致同意《钢研纳克检测技术股份有限公司 2023 ...

钢研纳克检测技术股份有限公司董事、监事、高级管理人员 公司第二届董事会第十九次会议和第二届监事会第十七次会议审议通过了 公司 2023 年半年度报告及其摘要。 公司全体董事、监事、高级管理人员，保证公司 2023 年半年度报告所披露 的信息内容真实、准确、完整，不存在任何虚假记载、误导性陈述或者重大遗漏。 （以下无正文） （本页无正文，为钢研纳克检测技术股份有限公司董事对公司 2023 年半年度报 告的书面确认意见签章页） 杨植岗： 汤建新： 黄沙棘： 李 晗： 曲选辉： 张晓维： 夏 宁： 签署的对公司 2023 年半年度报告的书面确认意见 根据《中华人民共和国证券法（2019 年修订）》、《深圳证券交易所创业板股 票上市规则》等相关规定要求，公司董事、监事、高级管理人员在全面审阅公司 2023 年半年度报告后，发表意见如下： 公司 2023 年半年度报告的编制符合法律、行政法规、公司章程和公司内部 管理制度的各项规定，公司严格按照上市公司财务制度规范运作，2023 年半年 度报告真实、准确、全面地反映了本报告期的财务状况和经营成果。 年 月 日 （本页无正文，为钢研纳克检测技术股份有限公司监事对公司 20 ...

钢研纳克检测技术股份有限公司独立董事 关于第二届董事会第十九次会议相关事项的独立意见 根据《公司法》《上市公司治理准则》《深圳证券交易所创业板股票上市规则》 《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运作》《关 于在上市公司建立独立董事制度的指导意见》《独立董事工作制度》及《公司章程》 等有关规定，作为公司独立董事，本着实事求是的态度和对公司及全体股东负责的 精神，经认真审阅提交公司第二届董事会第十九次会议审议的议案，就公司第二 届董事会第十九次会议相关事项发表独立意见如下： 一 、关于《2023年半年度募集资金存放与使用情况的专项报告》的独立意 见 经审核，我们认为：《2023年半年度募集资金存放与使用情况的专项报告》 真实、准确、完整地反映了公司报告期内募集资金存放与使用情况，不存在任何 虚假记载、误导性陈述或重大遗漏。公司2023年半年度募集资金的存放与使用履 行了必要的程序，符合相关法律法规、规范性文件及《公司章程》《募集资金管 理制度》的相关规定，不存在募集资金存放与使用违法、违规或损害公司股东利 益，尤其是中小股东利益的情形。 综上所述，我们同意公司编制的《2023年半年度募 ...

证券代码：300797 证券简称：钢研纳克 钢研纳克检测技术股份有限公司 投资者关系活动记录表 | --- | --- | --- | |------------------------|--------------------------------------------|--------------------------------------------------------| | | | 编号：2023-005 | | | ■特定对象调研 □ | 分析师会议 | | 投资者关系活 | □媒体采访 □ | 业绩说明会 | | 动类别 | □新闻发布会 □ | 路演活动 | | | □现场参观 □ | 电话通讯 | | 参与单位名称及人员姓名 | 详见附件 | | | 活动时间 | 2023 年 6 月 20 日 | | | 地点 | 钢研纳克会议室 | | | 上市公司接待 | 财务总监兼董事会秘书 | 刘彬 | | 人员姓名 | 投资证券部 蔡翔 | | | | | 会议中公司相关人员与投资者就公司主营业务、发展战 | | | | 略、管理模式等情况进行了沟通交流，相关问题如下： | | | 1 ...

钢研纳克检测技术股份有限公司 证券代码：300797 证券简称：钢研纳克 | 年度，青岛纳克格尔木盐湖水试验站新场地开工建设；超声导波 2022 | | --- | | 检测、石化检测等新业务取得突破；海上风电项目再获突破。后续青岛纳 | | 克将继续增加技术设备方面投入，同时强化相关能源领域项目比如国家管 | | 网、海上风电等方面的市场开发、产品研发与合作，努力推进相关产品智 | | 能化升级等等。 | | 2、子公司纳克微束除了研发场发射扫描电镜外，后期是否会进一步 | | 研发透射电镜、冷冻电镜？ | | 投资者您好，公司将根据现有项目产品研发进度，市场开发等情况等， | | 逐步推进扫描电子显微镜系列产品的开发和推广。感谢关注。 | | 3、请问纳克微束以后的研发重点侧重于那个具体行业，如医疗？还 | | 是半导体等？谢谢 | | 公司控股子公司纳克微束专注于提供高质量场发射扫描电镜产品，该 | | 产品为通用型仪器设备，可用于材料科学、生命科学、地质勘探、工业失 | | 效分析等领域。感谢关注。 | | 4、请问董秘，公司的场发射扫描电镜及质谱仪、光谱仪等科学仪器， | | 在半导体和锂电新能源行 ...

钢研纳克检测技术股份有限公司 关于举行2022年度网上业绩说明会的公告 证券代码：300797 证券简称：钢研纳克 公告编号：2023-029 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性 陈述或重大遗漏。 钢研纳克检测技术股份有限公司（以下简称"公司"）已于2023年4月20日在巨潮资讯网 （http://www.cninfo.com.cn/）披露了公司2022年年度报告及其摘要，为便于广大投资者进一步 了解公司2022年年度报告和经营情况，公司定于2023年5月26日（星期五）15:00-17:00在全景网 举办2022年度网上业绩说明会。本次业绩说明会将采用网络远程的方式举行，投资者可登陆全 景网"投资者关系互动平台"（http://rs.p5w.net）参与本次年度业绩说明会，进行互动与交流。 届时，出席本次年度业绩网上说明会的人员有：公司董事长、总经理杨植岗先生，财务总 监兼董事会秘书刘彬先生，独立董事夏宁先生，公司保荐代表人张翊维先生。 钢研纳克检测技术股份有限公司董事会 2023年5月22日 （问题征集专题页面二维码） 欢迎广大投资者积极参与本次网上业绩说明会！ ...

Financial Performance - The company's operating revenue for 2022 was ¥815,419,867.85, representing a 16.22% increase compared to ¥701,636,126.18 in 2021[24]. - The net profit attributable to shareholders for 2022 was ¥113,842,380.06, a 35.22% increase from ¥84,192,019.48 in 2021[24]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥80,647,992.72, up 31.57% from ¥61,297,954.06 in 2021[24]. - The total assets at the end of 2022 reached ¥1,667,923,982.82, a 21.31% increase from ¥1,374,892,524.74 at the end of 2021[24]. - The basic earnings per share for 2022 was ¥0.4587, reflecting a 35.23% increase from ¥0.3392 in 2021[24]. - The company generated a net cash flow from operating activities of ¥120,852,177.40, which is a 20.05% increase compared to ¥100,669,130.41 in 2021[24]. - The company reported a total of 33,194,387.34 in non-recurring gains for 2022, compared to 22,894,065.42 in 2021[30]. - In 2022, the company achieved operating revenue of 815.42 million yuan, a year-on-year increase of 16.22%[60]. - The net profit attributable to shareholders reached 113.84 million yuan, reflecting a growth of 35.22% compared to the previous year[60]. - The total operating revenue for 2022 reached ¥815,419,867.85, representing a year-on-year increase of 16.22% compared to ¥701,636,126.18 in 2021[70]. Dividend and Share Capital - The company reported a cash dividend of 1.34 RMB per 10 shares (including tax) and a capital reserve increase of 5 shares for every 10 shares held[6]. - The total share capital of the company is 255,010,000 shares[6]. - The company plans to distribute a cash dividend of RMB 1.34 per 10 shares, totaling RMB 34,171,340 for the year 2022[174]. - The company will increase its capital stock by 5 shares for every 10 shares held, using capital reserves for the distribution[174]. - The cash dividend distribution represents 100% of the total profit distribution amount[175]. - The company had a total of 255,010,000 shares as of the end of 2022, which serves as the basis for the dividend distribution[174]. Risk Management and Governance - The company emphasizes the importance of risk management in its future development outlook, highlighting potential operational risks[6]. - The financial report is guaranteed to be true, accurate, and complete by the company's management team, including the CEO and accounting head[6]. - The company maintains independence from its controlling shareholder in business, personnel, assets, and finance[126]. - There were no guarantees provided for the controlling shareholder, nor any non-operating fund occupation[128]. - The company strictly adheres to information disclosure regulations, ensuring timely and accurate information for investors[128]. - The governance practices align with legal and regulatory requirements without significant discrepancies[129]. - The company revised internal control regulations and improved its governance structure during the reporting period[122]. - The board of directors consists of 7 members, including 3 independent directors, meeting legal requirements[124]. - The company has established specialized committees under the board, including a strategy committee and an audit committee[124]. Research and Development - The company has 103 ongoing research projects, including 54 national projects and 49 self-initiated projects, and completed the revision of 41 standards[56]. - The company received 14 patent authorizations and 5 software copyrights in 2022, reflecting its commitment to research and innovation[66]. - Research and development expenses increased by 70.86% to ¥101,337,128.39, primarily due to the establishment of the Nake Microbeam company[80]. - The number of R&D personnel rose by 33.96% to 142, with a significant increase in the number of master's and doctoral degree holders[81]. - The company is enhancing its technological innovation capabilities and implementing a long-term equity incentive plan to encourage innovation among scientific talents[109]. Market Expansion and Product Development - The company is focusing on expanding its market presence and enhancing its product offerings in the detection analysis instrument sector, which is crucial for high-end manufacturing[38]. - The company aims to reduce reliance on foreign products by promoting domestic testing and analysis instruments, which are gaining market acceptance[38]. - The analysis instrument segment saw significant sales growth, with products like ICP spectrometers and gas analyzers reaching historical sales highs[61]. - The company plans to launch three new products in 2023, focusing on advanced testing technologies to enhance market competitiveness[151]. - Steel Research Nack aims to increase its market share by 10% in the next fiscal year through strategic partnerships and market expansion initiatives[151]. Internal Control and Compliance - The internal control system was updated and improved, completing the revision of 67 internal control regulations to ensure compliance and effectiveness in decision-making processes[196]. - The internal control self-evaluation report indicates that 96.21% of the total assets and 99.96% of the total revenue of the evaluated units are included in the company's consolidated financial statements[198]. - The internal control audit confirmed that the company’s decision-making processes are effective and compliant with regulations[200]. - The company’s internal control system is designed to prevent and detect fraud effectively[200]. - The internal control audit report received a standard unqualified opinion, indicating no major issues were found[200]. Employee Management and Remuneration - The total number of employees at the end of the reporting period was 1,199, with 828 being technical personnel[168]. - The company has 39 employees with doctoral degrees and 271 with master's degrees, indicating a strong educational background among its workforce[169]. - Total remuneration for directors, supervisors, and senior management during the reporting period amounted to 4.84 million CNY[157]. - The company’s remuneration policy is based on profitability and performance assessment[156]. - The performance evaluation targets for the first release period require a compound annual growth rate (CAGR) of net profit of no less than 15.00% for 2022, based on 2020 performance, and a weighted average return on equity (ROE) of no less than 11.00%[185]. Strategic Focus and Future Outlook - The company is actively expanding its calibration business, enhancing its capabilities in metallurgy, petrochemicals, and rail transportation sectors[62]. - The company is experiencing stable growth in business and asset scale, necessitating timely adjustments in management to adapt to market changes[115]. - The strategic focus for the next year includes increasing resource investment in market development and brand building[108]. - The management provided guidance for 2023, projecting a revenue target of 600 million RMB, which would represent a growth of 20%[151]. - The company is committed to sustainability, with plans to implement eco-friendly practices in its operations by 2024[151].

Financial Performance - The company's revenue for Q1 2023 was CNY 176,961,219.88, representing a 21.67% increase compared to CNY 145,444,649.48 in the same period last year[5] - Net profit attributable to shareholders decreased by 33.81% to CNY 9,847,337.32 from CNY 14,877,977.08 year-on-year[5] - Basic earnings per share fell by 33.72% to CNY 0.0397 from CNY 0.0599 in the same period last year[5] - Net profit for Q1 2023 was CNY 3,533,619.41, a significant decrease of 76.3% compared to CNY 14,877,977.08 in Q1 2022[18] - The company reported a decrease in comprehensive income to CNY 3,524,388.84 from CNY 14,868,981.83 in Q1 2022[19] Cash Flow - The net cash flow from operating activities was negative at CNY -80,585,200.94, a decline of 33.04% compared to CNY -60,570,937.90 in the previous year[5] - Cash flow from operating activities showed a net outflow of CNY 80,585,200.94, worsening from a net outflow of CNY 60,570,937.90 in Q1 2022[21] - The net cash flow from investment activities was -37,544,453.78 CNY, compared to -40,125,411.84 CNY in the previous period[22] - The net cash flow from financing activities was -645,425.58 CNY[22] - The company experienced a net decrease in cash and cash equivalents of -118,768,000.22 CNY during the quarter[22] Assets and Liabilities - Total assets decreased by 3.80% to CNY 1,604,541,612.25 from CNY 1,667,923,982.82 at the end of the previous year[5] - Current assets decreased to CNY 868,569,016.74 from CNY 948,505,066.14 at the beginning of the year, reflecting a decline of approximately 8.4%[13] - Cash and cash equivalents decreased to CNY 263,403,231.57 from CNY 383,021,120.32, representing a decline of about 31.3%[13] - Total current liabilities decreased to CNY 428,167,023.95 from CNY 486,768,542.88, a reduction of approximately 12%[14] - The company's total liabilities decreased to CNY 515,284,698.23 from CNY 559,026,732.53, a decrease of approximately 7.8%[14] Expenses - Total operating costs rose to CNY 182,117,924.39, up 37.6% from CNY 132,373,116.53 year-on-year[16] - Research and development expenses increased by 59.09% to CNY 20,921,295.95, attributed to the establishment of a new company focused on micro-beam research[7] - Management expenses surged by 90.55% to CNY 32,270,934.94, primarily due to increased employee compensation and share-based payment expenses[7] - Sales expenses rose to CNY 26,100,880.60, an increase of 26.5% compared to CNY 20,586,543.24 in the same period last year[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 12,906[9] - The total equity attributable to shareholders increased to CNY 956,786,970.54, up from CNY 943,951,155.79 in the previous year[18] Other Information - The company received government subsidies amounting to CNY 5,337,869.12 during the reporting period[6] - The company has not disclosed any new product developments or market expansion strategies in the current report[12] - The report for the first quarter was not audited[23]